Quick Verdict
Angiotensin (1-7)
Risk
Half-life
—
ARA-290
Risk
Half-life
~3 hours
Side-by-Side Comparison
About Angiotensin (1-7)
Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.
A heptapeptide formed from angiotensin II via ACE2 cleavage, or from angiotensin I via neprilysin. Acts as the endogenous counter-regulatory axis to angiotensin II — producing vasodilation, anti-fibrotic, and metabolic benefits via the Mas receptor.
Research Areas
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Angiotensin (1-7)
Browse directory →
Providers offering
ARA-290
12 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.